Search

Your search keyword '"Gómez-Peralta F"' showing total 104 results

Search Constraints

Start Over You searched for: Author "Gómez-Peralta F" Remove constraint Author: "Gómez-Peralta F"
104 results on '"Gómez-Peralta F"'

Search Results

14. Hacia un manejo integral del paciente con diabetes y obesidad. Posicionamiento de la SEMI, SED, redGDPS, SEC, SEEDO, SEEN, SEMERGEN y SEMFYC

18. Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition

19. 129TiP Metformin (MF) in the prevention of hyperglycemia (HG) in patients (pts) with PIK3CA-mutated, hormone receptor (HR)[+]/HER2[–] advanced breast cancer (ABC) treated with alpelisib (ALP) plus fulvestrant (F): METALLICA

21. [Treatment of type 2 diabetes mellitus in elderly patients]

26. Diabetes y cirugía II: Principios generales de tratamiento

27. Position statement: hypoglycemia management in patients with diabetes mellitus. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition

28. Diabetes y cirugía II: Principios generales de tratamiento

30. Profile of semaglutide in the management of type 2 diabetes: design, development, and place in therapy

35. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

36. Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review.

37. Diabetes Management Based on the Phenotype and Stage of the Disease: An Expert Proposal from the AGORA Diabetes Collaborative Group.

38. Revolutionizing the management of diabetes: The promise of connected insulin pens and caps.

39. Nocturnal Glucose Profile According to Timing of Dinner Rapid Insulin and Basal and Rapid Insulin Type: An Insulclock ® Connected Insulin Cap-Based Real-World Study.

40. Preventing alpelisib-related hyperglycaemia in HR+/HER2-/ PIK3CA -mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial.

41. Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study.

42. Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study.

43. GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms.

44. Usefulness of circulating EPAC1 as biomarkers of therapeutic response to GLP-1 receptor agonists.

45. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN).

47. Perceptions about the Management of Patients with DM2 and COVID-19 in the Hospital Care Setting.

48. Patient Preferences for Pharmacological Diabetes Treatment Among People with Diabetes in Spain: A Discrete Choice Experiment.

49. Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study.

Catalog

Books, media, physical & digital resources